Clorox Company (The) (NYSE:CLX) – Analysts at Jefferies Group reduced their Q2 2018 EPS estimates for Clorox Company (The) in a research note issued to investors on Wednesday. Jefferies Group analyst K. Grundy now anticipates that the company will post earnings of $1.19 per share for the quarter, down from their prior forecast of $1.32. Jefferies Group currently has a “Hold” rating and a $132.00 target price on the stock. Jefferies Group also issued estimates for Clorox Company (The)’s Q3 2018 earnings at $1.30 EPS, Q4 2018 earnings at $1.66 EPS, FY2018 earnings at $5.61 EPS, FY2019 earnings at $5.96 EPS and FY2020 earnings at $6.32 EPS.

A number of other analysts have also commented on the stock. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub lowered shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Finally, Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and a consensus target price of $128.72.

ILLEGAL ACTIVITY NOTICE: “Q2 2018 EPS Estimates for Clorox Company (The) Lowered by Analyst (CLX)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/q2-2018-eps-estimates-for-clorox-company-the-lowered-by-analyst-clx/1685848.html.

Clorox Company (CLX) traded down $0.38 during mid-day trading on Monday, reaching $127.73. 865,646 shares of the company traded hands, compared to its average volume of 1,124,065. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. The firm has a market capitalization of $16,518.32, a P/E ratio of 23.08, a P/E/G ratio of 3.50 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.48 billion. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.36 earnings per share.

A number of institutional investors have recently added to or reduced their stakes in CLX. BlackRock Inc. raised its stake in Clorox Company (The) by 1,402.2% during the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after acquiring an additional 9,698,542 shares in the last quarter. Janus Henderson Group PLC raised its stake in Clorox Company (The) by 8,008.5% during the second quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after acquiring an additional 1,307,153 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after buying an additional 649,766 shares in the last quarter. APG Asset Management N.V. increased its stake in shares of Clorox Company (The) by 30.9% in the third quarter. APG Asset Management N.V. now owns 1,301,915 shares of the company’s stock valued at $171,736,000 after buying an additional 307,700 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of Clorox Company (The) by 24.6% in the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock valued at $178,433,000 after buying an additional 265,200 shares in the last quarter. Hedge funds and other institutional investors own 71.54% of the company’s stock.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the transaction, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is owned by company insiders.

The company also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a yield of 2.63%. Clorox Company (The)’s dividend payout ratio (DPR) is currently 61.88%.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Earnings History and Estimates for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.